Activities
A New Advent in Hemophilia: Healthcare Economics Associated With Emerging Gene Therapies
0290-0000-20-381-H01-P
This webinar will examine the clinical and economic impact of acute and long-term bleeding events for patients with hemophilia.
1.00
Economic Implications of Osteoporotic Fractures in Postmenopausal Women
0290-0000-20-380-H01-P
This article will review several pharmacologic therapies used for the prevention and treatment of osteoporosis that pharmacists need to be familiar with to support reduction in fracture risk for their patients.
1.00
HER2+ Metastatic Breast Cancer: What Targeted Therapy Means for Managed Care
0290-0000-20-367-H01-P
This activity will examine the role and use of biomarker testing for HER2+ breast cancer and its impact on therapy decisions.
1.50
Hepatocellular Carcinoma: The Evolving Treatment Landscape and Cost Utilization Strategies
0290-0000-20-368-H01-P
This activity will determine ways in which care coordination in the treatment of hepatocellular carcinoma (HCC) can impact overall utilization resources.
1.50